Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier

Biomaterials

Volumn 35, Issue 13, 2014, Pages 4185-4194

  Zhou, Ting ^a   Zhou, Xiaoming ^a   Xing, Da ^a  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

Author keywords

Cancer cell targeted; Charge reversal polyelectrolyte; Drug delivery; Graphene oxide; PH responsive release

Indexed keywords

CANCER CELLS; CONFOCAL LASER SCANNING MICROSCOPY; FUNCTIONALIZED GRAPHENE; GRAPHENE OXIDES; INTRACELLULAR COMPARTMENTS; PH-RESPONSIVE; TARGETED DRUG DELIVERY; THERAPEUTIC EFFICIENCY;

CELLS; CYTOLOGY; DRUG DELIVERY; GRAPHENE; POLYELECTROLYTES;

LOADING;

DOXORUBICIN; GRAPHENE OXIDE; NANOCARRIER; POLYELECTROLYTE; ANTINEOPLASTIC AGENT; DRUG CARRIER; GRAPHITE;

ABSORPTION SPECTROSCOPY; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CARBOXYLATION; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; COVALENT BOND; CYTOPLASM; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TRANSPORT; ENDOCYTOSIS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURFACE CHARGE; ZETA POTENTIAL; CHEMISTRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GRAPHITE; HUMANS; HYDROGEN-ION CONCENTRATION;

EID: 84896820700     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.044     Document Type: Article

References (54)

1. Kang B., Li J., Chang S., Dai M., Ren C., Dai Y., et al. Subcellular tracking of drug release from carbon nanotube vehicles in living cells. Small 2012, 8:777-782.
2. Langer R. Drug delivery and targeting. Nature 1998, 392:5-10.
3. Zhang Q., Liu F., Nguyen K.T., Ma X., Wang X., Xing B., et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery. Adv Funct Mater 2012, 22:5144-5156.
4. Miao Q., Xu D., Wang Z., Xu L., Wang T., Wu Y., et al. Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents. Biomaterials 2010, 31:7364-7375.
5. Chung J.W., Lee K.A., Neikirk C., Nelson C.M., Priestley R.D. Photoresponsive coumarin-stabilized polymeric nanoparticles as a detectable drug carrier. Small 2012, 8:1693-1700.
6. Liu P., Yu H., Sun Y., Zhu M., Duan Y. AmPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Biomaterials 2012, 33:4403-4412.
7. Jiang T., Zhang Z., Zhang Y., Lv H., Zhou J., Li C., et al. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 2012, 33:9246-9258.
8. Abraham S.A., Waterhouse D.N., Mayer L.D., Cullis P.R., Madden T.D., Bally M.B. The liposomal formulation of doxorubicin. Methods Enzymol 2005, 391:71-97.
9. Wang H., Zhao P., Liang X., Gong X., Song T., Niu R., et al. Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 2010, 31:4129-4138.
10. Son J.S., Appleford M., Ong J.L., Wenke J.C., Kim J.M., Choi S.H., et al. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres. JControl Release 2011, 153:133-140.
11. Gong X., Peng S., Wen W., Sheng P., Li W. Design and fabrication of magnetically functionalized core/shell microspheres for smart drug delivery. Adv Funct Mater 2009, 19:292-297.
12. Wang T., Chai F., Fu Q., Zhang L., Liu H., Li L., et al. Uniform hollow mesoporous silica nanocages for drug delivery invitro and invivo for liver cancer therapy. JMater Chem 2011, 21:5299-5306.
13. Zhang L., Wang T., Lei Y., Liu C., Wang C., Liu H., et al. General route to multifunctional uniform york/mesoporous silica shell nanocapsules: a platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Chem Eur J 2012, 18:12512-12521.
14. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010, 9:172-178.
15. Farokhzad O.C., Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3:16-20.
16. Youan B.B. Impact of nanoscience and nanotechnology on controlled drug delivery. Nanomedicine 2008, 3:401-406.
17. Geim A.K., Novoselov K.S. The rise of graphene. Nat Mater 2007, 6:183-191.
18. Sun X., Liu Z., Welsher K., Robinson J.T., Goodwin A., Zaric S., et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008, 1:203-212.
19. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. JAm Chem Soc 2008, 130:10876-10877.
20. Wang C., Li J., Amatore C., Chen Y., Jiang H., Wang X.M. Gold nanoclusters and graphene nanocomposites for drug delivery and imaging of cancer cells. Angew Chem Int Ed Engl 2011, 50:11644-11648.
21. Chen M.L., He Y.J., Chen X.W., Wang J.H. Quantum-dot-conjugated graphene as a probe for simultaneous cancer-targeted fluorescent imaging, tracking, and monitoring drug delivery. Bioconjug Chem 2013, 24:387-397.
22. Huang P., Xu C., Lin J., Wang C., Wang X., Zhang C., et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1:240-250.
23. Georgakilas V., Otyepka M., Bourlinos A.B., Chandra V., Kim N., Kemp K.C., et al. Functionalization of graphene: covalent and non-covalent approaches, derivatives and applications. Chem Rev 2012, 112:6156-6214.
24. Wang H., Chen T., Wu S., Chu X., Yu R. Anovel biosensing strategy for screening G-quadruplex ligands based on graphene oxide sheets. Biosens Bioelectron 2012, 34:88-93.
25. Momparler R.L., Karon M., Siegel S.E., Avila F. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res 1976, 36:2891-2895.
26. Fornari F.A., Randolph J.K., Yalowich J.C., Ritke M.K., Gewirtz D.A. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 1994, 45:649-656.
27. Timko B.P., Dvir T., Kohane D.S. Remotely triggerable drug delivery systems. Adv Mater 2010, 22:4925-4943.
28. You J., Zhang G., Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano 2010, 4:1033-1041.
29. Wu G., Mikhailovsky A., Khant H.A., Fu C., Chiu W., Zasadzinski J.A. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. JAm Chem Soc 2008, 130:8175-8177.
30. Lee Y., Fukushima S., Bae Y., Hiki S., Ishii T., Kataoka K. Aprotein nanocarrier from charge-conversion polymer in response to endosomal pH. JAm Chem Soc 2007, 129:5362-5363.
31. Miyata K., Oba M., Nakanishi M., Fukushima S., Yamasaki Y., Koyama H., et al. Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity. JAm Chem Soc 2008, 130:16287-16294.
32. Su J., Chen F., Cryns V.L., Messersmith P.B. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. JAm Chem Soc 2011, 133:11850-11853.
33. Zhang C., Yang Y.Q., Huang T.X., Zhao B., Guo X.D., Wang J.F., et al. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. Biomaterials 2012, 33:6273-6283.
34. Dong D.W., Xiang B., Gao W., Yang Z.Z., Li J.Q., Qi X.R. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Biomaterials 2013, 34:4849-4859.
35. Yu J., Kuo C., Chen C.M., Shin Y., Jyh P. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids Surf B Biointerfaces 2012, 89:1-9.
36. 4 nanoparticles hybrid for controlled targeted drug carriers. JMater Chem 2009, 19:2710-2714.
37. Yang X., Wang Y., Huang X., Ma Y., Huang Y., Yang R., et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. JMater Chem 2011, 21:3448-3454.
38. Ding C., Gu J., Qu X., Yang Z. Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker. Bioconjug Chem 2009, 20:1163-1170.
39. Guo S., Huang Y., Jiang Q., Sun Y., Deng L., Liang Z., et al. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010, 4:5505-5511.
40. Han L., Zhao J., Zhang X., Cao W., Hu X., Zou G., et al. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano 2012, 6:7340-7351.
41. Lee Y., Ishii T., Cabral H., Kim H.J., Seo J.H., Nishiyama N., et al. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. Angew Chem Int Ed Engl 2009, 48:5309-5312.
42. Lee Y., Miyata K., Oba M., Ishii T., Fukushima S., Han M., et al. Charge-conversion ternary polyplex with endosome disruption moiety: a technique for efficient and safe gene delivery. Angew Chem Int Ed Engl 2008, 47:5163-5166.
43. Sun B., Lynn D.M. Release of DNA from polyelectrolyte multilayers fabricated using 'charge-shifting' cationic polymers: tunable temporal control and sequential, multi-agent release. JControl Release 2010, 148:91-100.
44. Xu P., Van Kirk E.A., Zhan Y., Murdoch W.J., Radosz M., Shen Y. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew Chem Int Ed Engl 2007, 46:4999-5002.
45. Chen T., Shukoor M.I., Wang R., Zhao Z., Yuan Q., Bamrungsap S., et al. Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging. ACS Nano 2011, 5:7866-7873.
46. Liu X., Zhang J., Lynn D.M. Polyelectrolyte multilayers fabricated from 'charge-shifting' anionic polymers: a new approach to controlled film disruption and the release of cationic agents from surfaces. Soft Matter 2008, 4:1688-1695.
47. Wang H., Zhang Q., Chu X., Chen T., Ge J., Yu R. Graphene oxide-peptide conjugate as an intracellular protease sensor for caspase-3 activation imaging in live cells. Angew Chem Int Ed Engl 2011, 50:7065-7069.
48. Liu Z., Fan A.C., Rakhra K., Sherlock S., Goodwin A., Chen X., et al. Supramolecular stacking of doxorubicinon carbon nanotubes for invivo cancer therapy. Angew Chem Int Ed Engl 2009, 48:7668-7672.
49. Lee Y.K., Choi J., Wang W., Lee S., Nam T.H., Choi W.S., et al. Nullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drug. ACS Nano 2013, 7:8484-8497.
50. Robinson J.T., Tabakman S.M., Liang Y., Wang H., Casalongue H.S., Vinh D., et al. Utrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. JAm Chem Soc 2011, 133:6825-6831.
51. Elbakry A., Zaky A., Liebl R., Rachel R., Goepferich A., Breunig M. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 2009, 9:2059-2064.
52. Akinc A., Thomas M., Klibanov A.M., Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. JGene Med 2005, 7:657-663.
53. Li R., Wu R., Zhao L., Hu Z., Guo S., Pan X., et al. Folate and difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cells. Carbon 2011, 49:1797-1805.
54. Yang X., Zhang X., Liu Z., Ma Y., Huang Y., Chen Y. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. JPhys Chem C 2008, 112:17554-17558.